Français Néerlandais Japonais Chinois Allemand Espagnol Portugais

Major innovation in fight against pleural cancer

05 Apr 2016 | Health Nutrition, A region on the move

Lille hospital plays a key role in new treatment for pleural cancer.

For over 10 years, medicine had made no progress in treating cancer of the pleura, the membrane lining the lungs.

But now the Bio-MAPS program, launched by Dr. Gérard Zalcman in close cooperation with 70 French hospital groups, has shown that Bevacizumab is effective in treating pleural cancer, significantly reducing mortality risk in 23% of patients who were treated with it.

Dr. Arnaud Scherpereel, head of pulmonology and thoracic oncology at Lille University Hospital Center (CHRU) and coordinator of the Bevacizumab project, stresses that the treatment is equally effective in all patient sub-groups, including those with the worst prognosis factors.

As a result, this new treatment solution is becoming the first-line therapy for patients with pleural cancer.

Back to news

News

Coca-Cola is investing €19M in Dunkirk

Coca-Cola European Partners will invest €19M in its largest plant in France, located in Socx (near Dunkirk). A new ultra-modern glass bottle production line is scheduled to open in 2019.

Rafaut opens a next-generation factory in Valenciennes

The aeronautics sector has been constantly growing in Hauts-de-France. And for good reason, after Safran’s new location in Rosult and SKF’s development in Rouvignies, Rafaut is investing €20M to create a new...

All news